Global Congress on Bladder Cancer 2018

Viewing 1-20 of 22 articles

Upper Tract Urothelial Carcinoma - Adjuvant Chemotherapy for all Patients?

Perioperative Chemotherapy in Cisplatin “Unfit” Patients

Controlling Symptoms in Metastatic Bladder Cancer

Saving Bladders with Brachytherapy Using Robot-Assisted Laparoscopically Performed Implantations for Solitary Muscle-Invasive Bladder Tumors

VISTA, Phase 3 Trial of Vicinium™, an EPCAM-Targeted Pseudomonas Exotoxin, in BCG – Unresponsive Non-Muscle Invasive Bladder Cancer

BCG vs Chemohyperthermia with Mitomycin C for High-Risk Non-Muscle Invasive Bladder Carcinoma: Preliminary Results of HIVEC-HR Randomized Clinical Trial

Bladder Cancer in the "Golden Years"

Chemohypertheramia with Mitomycin C and COMBAT System in High Risk Non-Muscle Invasive Bladder Cancer: A New Alternative?

How Can Diagnostic Imaging Influence the Treatment of Advanced Bladder Cancer?

Practical Considerations: What Every Clinician Should Know About Immune-Oncology

Atezolizumab as First-line Therapy in Patients with Cisplatin Ineligible Locally Advanced or Metastatic Urothelial Cancer: Efficacy by PD-L1 Status Over Time

Adjuvant Radiotherapy After Cystectomy: A Good Idea?

Variant Histology: What Pathology Can Tell You

Robotic Cystectomy: What is the Evidence?

Systemic Therapy in Advanced Urothelial Carcinoma: The Role of Chemotherapy

Immunoncology in Advanced Urothelial Carcinoma

Immuno Oncology in Advanced Bladder Cancer

Contemporary Advances in the Endoscopic Evaluation and Diagnosis of Bladder Cancer

What’s in the Boiling Pot of Non-Muscle Invasive Bladder Cancer

What You Need to Remember According to the Clinical Oncologist

1
2

email news signup